Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
Henry
David A
DA
School of Medicine and Public Health, University of Newcastle, New South Wales, Australia. david.henry@newcastle.edu.au
Hill
Suzanne R
SR
Harris
Anthony
A
D001315:Australia; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004341:Drug Evaluation; D004345:Drug Industry / Q000458:organization & administration*; D017850:Economics, Pharmaceutical; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D011050:Policy Making; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000191:economics*; D013673:Technology Assessment, Biomedical / Q000191:economics / Q000458:organization & administration*; D016896:Treatment Outcome; D006113:United Kingdom